Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 May;151(1):128-43.
doi: 10.1038/sj.bjp.0707174. Epub 2007 Mar 12.

Correlation of apparent affinity values from H3-receptor binding assays with apparent affinity (pKapp) and intrinsic activity (alpha) from functional bioassays

Affiliations

Correlation of apparent affinity values from H3-receptor binding assays with apparent affinity (pKapp) and intrinsic activity (alpha) from functional bioassays

E A Harper et al. Br J Pharmacol. 2007 May.

Abstract

Background and purpose: Agonist apparent affinities (pK(I)') in histamine H(3)-receptor binding assays were higher than expected from apparent affinity values (pK(app)) estimated in bioassay. Here, we investigate whether the degree of pK(I)' overestimation is related to agonist intrinsic efficacy, by studying the effect of buffer composition on the pK(I)' of ligands with varying intrinsic activity.

Experimental approach: In the guinea-pig ileum bioassay, intrinsic activity (alpha) was determined from the maximal inhibition of the contraction produced by increasing agonist concentration. pK(app) values were estimated using the method of Furchgott. The pK(L) of [(3)H]clobenpropit in guinea-pig cerebral cortex was estimated by saturation analysis in 20 mM HEPES-NaOH buffer (buffer B(0,0,0)), or buffer B(0,0,0) containing 70 mM CaCl(2), 100 mM NaCl and 100 mM KCl (buffer B(0.07,0.1,0.1)). PK(I) values were determined in competition studies in both buffers.

Key results: [(3)H]clobenpropit saturation isotherms had n (H) values of unity in both buffers. In buffer B(0.07,0.1,0.1), agonist pK(I)' values were closer to pK(app) values than in buffer B(0,0,0) but were associated with n (H) values <1. A two-site analysis of agonist data in buffer B(0.07, 0.1, 0.1) provided a better fit than a one-site fit and low affinity values (pK(IL)) were comparable to pK(app). Differences between the pK(I)' in buffer B(0,0,0) and pK(IL) values in buffer B(0.07,0.1,0.1) (DeltapK) were correlated with alpha.

Conclusions and implications: H(3)-receptor binding assays conducted in buffer B(0,0,0) and buffer B(0.07,0.1,0.1) can provide a measure of ligand affinity (pK(app)) and intrinsic efficacy. The assay predicts that some ligands previously classified as H(3)-receptor antagonists may possess residual intrinsic efficacy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structures of histamine H3-receptor ligands.
Figure 2
Figure 2
Effect of histamine H3-receptor ligands on the electrically induced contraction of the guinea-pig ileum. Each point represents the mean±s.e.m. of determinations in at least three separate preparations (see Table 2).
Figure 3
Figure 3
Effect of EEDQ (0.3 μM) on (a) R-α-MH, (b) imetit, (c) S-α-MH and (d) histamine-induced inhibition of the electrically induced contraction of the guinea-pig ileum. Each point is the mean±s.e.m. of determinations in at least six separate preparations.
Figure 4
Figure 4
Representative saturation isotherms of [3H]clobenpropit to sites in guinea-pig cerebral cortex membranes in buffer B(0,0,0) (a and c) and buffer B(0.07,0.1,0.1) (b and d). The lines shown superimposed on the data points are the saturation isotherm obtained by fitting the Hill equation with nH constrained to unity to the data. Guinea-pig cortical membranes (1.6 mg) were incubated for 165 min at 21±3°C in a final volume of 0.5 ml with HEPES–NaOH buffer and [3H]clobenpropit. Total and nonspecific binding of [3H]clobenpropit were defined using buffer B(0,0,0) or buffer B(0.07,0.1,0.1) and 1 μM thioperamide, respectively. All determinations were made in triplicate.
Figure 5
Figure 5
Representative saturation isotherms of [3H]clobenpropit to sites in guinea-pig cerebral cortex membranes in (a) buffer B(0,0,0), (b) buffer B(0.03,0,0), (c) buffer B(0.07,0,0), (d) buffer B(0.1,0,0), (e) buffer B(0.2,0,0) and (f) buffer B(0.3,0,0). The lines shown superimposed on the data points are the saturation isotherm obtained by fitting the Hill equation with nH constrained to unity to the data. Guinea-pig cortical membranes (1.6 mg) were incubated for 165 min at 21±3°C in a final volume of 0.5 ml with HEPES–NaOH buffer and [3H]clobenpropit. Total and nonspecific binding of [3H]clobenpropit were defined using appropriate buffer and 1 μM thioperamide, respectively. All determinations were made in triplicate.
Figure 6
Figure 6
Effect of increasing concentration of CaCl2 in buffer B on (a) pKL and (b) Bmax of [3H]clobenpropit at sites in guinea-pig cerebral cortex membranes. The line shown superimposed on the data was obtained by fitting a hyperbolic function.
Figure 7
Figure 7
Competition curves for H3-receptor agonists and antagonists at sites labelled with [3H]clobenpropit in guinea-pig cerebral cortex. (a) Effect of increasing concentrations of ligands on [3H]clobenpropit binding (dpm). Data were obtained in a single experiment in buffer B(0,0,0) and buffer B(0.07,0.1,0.1) and errors are the mean±s.e.m. of triplicates. (b) Mean competition curve data for ligands, expressed as percentage specific binding, in buffer B(0,0,0) or (c) buffer B(0.07,0.1,0.1). Guinea-pig cortical membranes (1.6 mg) were incubated for 165 min at 21±3°C in a final volume of 0.5 ml with HEPES–NaOH buffer, [3H]clobenpropit (0.2 nM) and increasing concentrations of ligands. Total and nonspecific binding of [3H]clobenpropit were defined using appropriate buffer and 1 μM thioperamide, respectively. Data are the mean±s.e.m. of between four and six experiments (see Table 4). The lines shown superimposed on the data for imetit, chloroproxyfan and S-α-methylhistamine were obtained using a two-site fit. The line shown superimposed on the thioperamide data was obtained using a one-site fit.
Figure 8
Figure 8
Comparison of the apparent affinities (pKI or pKI′) of histamine H3-receptor agonists and antagonists obtained in buffer B(0,0,0) and in buffer B containing 70 mM CaCl2, 100 mM KCl and 100 mM NaCl (buffer B(0.07,0.1,0.1)). The broken line represents the line of identity.
Figure 9
Figure 9
Comparison of the affinities of histamine H3-receptor agonists (pKapp) and antagonists (pA2 or pKB) at H3-receptors in the guinea-pig ileum bioassay (see Table 2) with those estimated in radioligand binding assays (see Table 4). pKI or pKI′ values for (a) agonists and antagonists in standard buffer (B(0,0,0)), (b) agonists and antagonists in B(0.07,0.1,0.1), (c) agonists in B(0,0,0), (d) agonists in B(0.07,0.1,0.1), (e) antagonists in B(0.07,0.1,0.1) and (f) antagonists in B(0.07,0.1,0.1). The broken line represents the line of identity (y=x).
Figure 10
Figure 10
Comparison of (a) pKI′ and (b) pKIL values for agonists in buffer B(0.07,0.1,0.1) with ileum pKapp estimates.
Figure 11
Figure 11
Comparison of ligand ΔpK values and α measured in the guinea-pig ileum bioassay.
Figure 12
Figure 12
(a) The extended TCM as described by Samama et al. (1993). (b) The cubic TCM of Weiss et al. (1996). In both models, H is hormone, G is G protein and R is the inactive receptor state and R* the ‘active' state. To allow simple comparison of the models, the terms used for ‘inactive', Ri and ‘active' receptor states (Ra) in the model of Weiss et al. (1996) have been modified to R and R*, respectively.

Similar articles

Cited by

References

    1. Arias HR. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor. Arch Biochem Biophys. 1996;333:1–11. - PubMed
    1. Arrang JM, Garbarg M, Lancelot J-C, Lecomte J-M, Pollard H, Robba M, et al. Highly potent and selective ligand for histamine H3-receptors. Nature. 1987;327:117–123. - PubMed
    1. Arrang J-M, Roy J, Morgat J-L, Schunack W, Schwartz J-C. Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations. Eur J Pharmacol. 1990;188:219–227. - PubMed
    1. Barnes JC, Brown JD, Clarke NP, Clapham J, Evans DJ, O'Shaughnessy CTO. Pharmacological activity of VUF9153, an isothiourea histamine H3 receptor antagonist. Eur J Pharmacol. 1993;250:147–152. - PubMed
    1. Black J. The Nobel Prizes 1988. Almqvist & Wiksell International: Stockholm Sweden; 1988. Drugs from emasculated hormones: the principles of syntopic antagonism.

Publication types